All News #Library
Others
Harrow Reaffirms $270M–$280M 2025 Revenue Guidance
02 Feb 2026 //
GLOBENEWSWIRE
Imprimisrx Announces Leadership Changes
06 Oct 2025 //
GLOBENEWSWIRE
Harrow’s ImprimisRx Receives $34.9M Jury Verdict in Lawsuit
21 Nov 2024 //
BUSINESSWIRE
ImprimisRx Launches Fortisite Compounded Antibiotic Formulation
29 Sep 2022 //
BUSINESSWIRE
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
20 Dec 2021 //
BUSINESSWIRE
Harrow Health Announces Second Quarter 2021 Financial Results
10 Aug 2021 //
BUSINESSWIRE

Market Place
Sourcing Support